Sa1484 COMBINED NIVOLUMAB PLUS IPILIMUMAB THERAPY CAUSE HIGHER GRADE AND EARLIER IMMUNE-RELATED ADVERSE EVENTS HEPATITIS OCCURRENCE THAN SINGLE AGENT THERAPY
Nagashima, Hiroyuki, Sagawa, Tamotsu, Hirakawa, Masahiro, Waga, Eriko, Fujikawa, Koshi, Takahashi, YasuoVolume:
158
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(20)33929-9
Date:
May, 2020
Fichier:
PDF, 337 KB
2020